Nidhi S Chaudhry, MD
Internal Medicine · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 18 years
- Graduated 2008
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chaudhry’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A151365 · Current
Licensed to practise in California · since 2017 · expires 2026-11-30 · Maharashtra University of Health Sciences, Rajiv Gandhi Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$159,442
Medicare paid this office $159,442 for 271 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 122 | $42,396 | $164 |
| Return visit (30+ min) | 179 | $39,007 | $114 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 141 | $21,584 | $153 |
| Short return visit (20+ min) | 119 | $11,914 | $76 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 218 | $7,736 | $14 |
See all 18 services
| Long return visit (40+ min) | 122 | $42,396 | $164 |
| Return visit (30+ min) | 179 | $39,007 | $114 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 141 | $21,584 | $153 |
| Short return visit (20+ min) | 119 | $11,914 | $76 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 218 | $7,736 | $14 |
| Sarscv2 vac 30mcg trs-suc im | 41 | $6,556 | $137 |
| Sarscov2 vac 50 mcg/0.5ml im | 28 | $4,715 | $147 |
| Influenza vaccine split virus, preservative free | 53 | $4,389 | $81 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 15 | $4,363 | $291 |
| Admn sarscov2 vacc 1 dose | 66 | $4,127 | $52 |
| Administration of influenza virus vaccine | 55 | $2,140 | $38 |
| New patient visit (45+ min) | 21 | $1,988 | $95 |
| Hepatitis b vaccine, adult dosage (3 dose schedule) | 11 | $1,104 | $69 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $917 | $51 |
| Administration of hepatitis b vaccine | 11 | $612 | $38 |
| Administration of pneumococcal vaccine | 15 | $573 | $38 |
| Removal of impacted ear wax by washing | 17 | $332 | $18 |
| Automated urinalysis test | 15 | $33 | $2 |
Procedures year by year
| Procedure | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax by washing | – | – | – | – | 19 | 18 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
271 Original Medicare patients in 2024. Average age 73 · Under 65 5% · 85 and older 10% · Women 68% · Also on Medicaid 5% · Health risk score 0.99. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 64% · Coronary heart disease 20% · Diabetes 18% · Depression 18% · Chronic kidney disease 16% · Cancer 14% · Atrial fibrillation 13% · Heart failure 11% · Stroke 8% · COPD 7%.
The office billed $515,966, Medicare allowed $196,403 and paid $159,442; for 1,908 services of 41 kinds; $21,171 of it was for drugs given in the office and $138,271 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 271 | 1,908 | 73 | 0.99 | $515,966 | $159,442 |
| 2023 | 217 | 1,028 | 73 | 1.02 | $357,345 | $113,860 |
| 2022 | 192 | 762 | 73 | 1.00 | $302,942 | $92,960 |
| 2021 | 115 | 291 | 73 | 0.89 | $151,772 | $34,350 |
| 2020 | 71 | 185 | 69 | 1.08 | $73,594 | $13,586 |
| 2018 | 11 | 16 | 63 | 1.07 | $8,084 | $417 |
| 2017 | 96 | 307 | 63 | 3.60 | $53,830 | $23,162 |
| 2016 | 128 | 381 | 65 | 3.27 | $64,430 | $27,618 |
| 2015 | 58 | 205 | 64 | 3.42 | $33,550 | $14,495 |
| 2014 | 96 | 311 | 67 | 3.63 | $53,090 | $22,673 |
| 2013 | 37 | 111 | 65 | 2.60 | $17,800 | $7,404 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Long return visit (40+ min) | 100 | $31,179 | $162 |
| Return visit (30+ min) | 124 | $24,112 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 106 | $16,211 | $153 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 36 | $10,111 | $281 |
| Short return visit (20+ min) | 73 | $7,293 | $81 |
| New patient visit (45+ min) | 45 | $5,982 | $133 |
| Influenza vaccine split virus, preservative free | 37 | $2,730 | $72 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $2,126 | $193 |
| Sarscov2 vac 50 mcg/0.5ml im | 11 | $1,573 | $143 |
| Administration of influenza virus vaccine | 39 | $1,452 | $36 |
| Administration of pneumococcal vaccine | 37 | $1,343 | $36 |
| Admn sarscov2 vacc 1 dose | 21 | $1,016 | $48 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $907 | $50 |
| Removal of impacted ear wax by washing | 16 | $364 | $19 |
2022: 12 services
| Long return visit (40+ min) | 110 | $37,205 | $161 |
| Return visit (30+ min) | 94 | $13,621 | $108 |
| New patient visit (60+ min) | 45 | $7,553 | $168 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 27 | $7,505 | $278 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $7,254 | $154 |
| New patient visit (45+ min) | 27 | $3,619 | $134 |
| Influenza vaccine split virus, preservative free | 39 | $2,663 | $68 |
| Pneumococcal vaccine, 23-valent | 18 | $2,398 | $133 |
| Short return visit (20+ min) | 27 | $2,209 | $71 |
| Administration of pneumococcal vaccine | 44 | $1,637 | $36 |
| Administration of influenza virus vaccine | 44 | $1,589 | $36 |
| New patient visit (30+ min) | 13 | $1,043 | $80 |
2021: 7 services
| Long return visit (40+ min) | 51 | $12,484 | $160 |
| New patient visit (60+ min) | 44 | $7,964 | $181 |
| Return visit (30+ min) | 41 | $5,334 | $116 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,893 | $158 |
| New patient visit (45+ min) | 14 | $1,735 | $124 |
| Influenza vaccine split virus, preservative free | 17 | $1,109 | $65 |
| Administration of influenza virus vaccine | 18 | $379 | $21 |
2020: 4 services
| Return visit (30+ min) | 22 | $3,373 | $102 |
| Short return visit (20+ min) | 16 | $1,841 | $71 |
| Short return visit (20+ min) | 19 | $920 | $48 |
| Insertion of needle into vein for collection of blood sample | 14 | $53 | $3 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $9,716 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $4,019 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,214 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,997 | $166 |
| Hospital discharge day management, 30 minutes or less | 34 | $1,945 | $57 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $12,799 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,393 | $169 |
| Hospital discharge day management, 30 minutes or less | 52 | $3,041 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,622 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,728 | $86 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,270 | $85 |
2015: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $8,002 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,712 | $170 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,465 | $61 |
2014: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $11,019 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,261 | $158 |
| Hospital discharge day management, 30 minutes or less | 43 | $2,577 | $60 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,609 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,607 | $115 |
2013: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,925 | $58 |
| Hospital discharge day management, 30 minutes or less | 13 | $758 | $58 |
Medicaid work
$181,123 in 2019
Medicaid paid $181,123 for 3,150 billed services this clinician did in 2019, up to 197 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,532 | $173,668 |
| Short return visit (20+ min) | 1,245 | $5,101 |
| Return visit (30+ min) | 230 | $1,245 |
| VITAL SIGNS RECORDED | 55 | $615 |
| Blood test, lipids (cholesterol and triglycerides) | 13 | $247 |
| New patient visit (30+ min) | 12 | $203 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 12 | $44 |
| Medication list documented in medical record (COA) | 34 | $0 |
| Short return visit | 17 | $0 |
| 2019 | 3,150 | 9 | 197 | $181,123 |
| 2018 | 2,263 | 5 | 157 | $190,149 |
See the largest Medicaid services in earlier years
2018
| Clinic visit/encounter, all-inclusive | 1,618 | $187,144 |
| Short return visit (20+ min) | 540 | $2,242 |
| Return visit (30+ min) | 68 | $359 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 19 | $286 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 18 | $117 |
Drugs they prescribed that Part D paid
$128,040
Pharmacies billed $128,040 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (17 of 1,863) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,654 generic and 191 brand-name prescriptions · $128,040 in drug cost · 58 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 38 | $32,857 | $865 |
| Ozempic | 22 | $28,486 | $1,295 |
| Paxlovid | 27 | $2,797 | $104 |
| Rosuvastatin | 87 | $2,013 | $23 |
| Atorvastatin | 149 | $1,799 | $12 |
See all 49 drugs
| Eliquis | 38 | $32,857 | $865 |
| Ozempic | 22 | $28,486 | $1,295 |
| Paxlovid | 27 | $2,797 | $104 |
| Rosuvastatin | 87 | $2,013 | $23 |
| Atorvastatin | 149 | $1,799 | $12 |
| Losartan | 147 | $1,757 | $12 |
| Gabapentin | 68 | $1,583 | $23 |
| Sucralfate | 16 | $992 | $62 |
| Levothyroxine | 96 | $981 | $10 |
| Amlodipine Besylate | 100 | $758 | $8 |
| Estradiol | 12 | $566 | $47 |
| Cyclobenzaprine | 21 | $546 | $26 |
| Valsartan | 11 | $492 | $45 |
| Duloxetine | 25 | $484 | $19 |
| Ezetimibe | 14 | $459 | $33 |
| Pantoprazole | 38 | $378 | $10 |
| Lisinopril | 23 | $365 | $16 |
| Fluticasone Propionate | 33 | $356 | $11 |
| Mirtazapine | 11 | $353 | $32 |
| Albuterol Sulfate Hfa | 18 | $319 | $18 |
| Metoprolol | 20 | $315 | $16 |
| Escitalopram | 11 | $309 | $28 |
| Lantus Solostar | 12 | $276 | $23 |
| Omeprazole | 22 | $266 | $12 |
| Alendronate | 22 | $262 | $12 |
| Pregabalin | 11 | $244 | $22 |
| Hydralazine | 14 | $238 | $17 |
| Montelukast | 19 | $226 | $12 |
| Carvedilol | 22 | $183 | $8 |
| Clonazepam | 15 | $181 | $12 |
| Trazodone | 12 | $180 | $15 |
| Metformin | 16 | $177 | $11 |
| Metformin Hcl Er | 22 | $167 | $8 |
| Atenolol | 13 | $149 | $11 |
| Sertraline | 30 | $149 | $5 |
| Valacyclovir | 16 | $146 | $9 |
| Tamsulosin | 11 | $143 | $13 |
| Hydrochlorothiazide | 34 | $141 | $4 |
| Cephalexin | 14 | $118 | $8 |
| Sumatriptan | 14 | $115 | $8 |
| Folic Acid | 12 | $102 | $8 |
| Fluoxetine | 11 | $98 | $9 |
| Hydrocodone-Acetaminophen | 11 | $95 | $9 |
| Ondansetron Odt | 11 | $78 | $7 |
| Simvastatin | 13 | $76 | $6 |
| Clonidine | 11 | $69 | $6 |
| Losartan-Hydrochlorothiazide | 12 | $49 | $4 |
| Ondansetron | 12 | $44 | $4 |
| Allopurinol | 12 | $16 | $1 |
Year by year
| 2024 | 1,863 | 275 | 1% (17) | 10% | $128,040 |
| 2023 | 1,297 | 209 | None | None | $78,533 |
| 2022 | 749 | 178 | None | None | $45,253 |
| 2021 | 488 | 112 | 2% (11) | 11% | $26,497 |
| 2020 | 519 | 92 | None | None | $44,400 |
| 2019 | 1,083 | 123 | 2% (23) | 18% | $91,367 |
| 2018 | 554 | 95 | 3% (15) | None | $31,849 |
| 2017 | 54 | 23 | None | 24% | $2,567 |
| 2016 | 50 | 20 | None | 22% | $4,869 |
| 2015 | 48 | 22 | None | 27% | $1,570 |
| 2014 | 37 | 15 | None | None | $1,774 |
| 2013 | 58 | 22 | None | 22% | $1,641 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Symbicort | 13 | $5,457 | $420 |
| Atorvastatin | 127 | $1,940 | $15 |
| Rosuvastatin | 69 | $1,896 | $27 |
| Losartan | 100 | $1,488 | $15 |
| Levothyroxine | 90 | $1,184 | $13 |
| Gabapentin | 32 | $1,056 | $33 |
| Estradiol | 16 | $871 | $54 |
| Pregabalin | 13 | $784 | $60 |
| Amlodipine Besylate | 61 | $721 | $12 |
| Omeprazole | 21 | $498 | $24 |
| Montelukast | 23 | $468 | $20 |
| Tamsulosin | 14 | $386 | $28 |
| Lisinopril | 32 | $361 | $11 |
| Carvedilol | 11 | $212 | $19 |
| Fluticasone Propionate | 19 | $196 | $10 |
| Sertraline | 24 | $193 | $8 |
| Metoprolol | 11 | $175 | $16 |
| Simvastatin | 18 | $171 | $10 |
| Atenolol | 12 | $158 | $13 |
| Alendronate | 19 | $152 | $8 |
| Hydrochlorothiazide | 27 | $109 | $4 |
| Clonazepam | 11 | $93 | $8 |
| Allopurinol | 16 | $89 | $6 |
| Metformin | 22 | $83 | $4 |
| Folic Acid | 14 | $75 | $5 |
| Vitamin D2 | 11 | $64 | $6 |
| Cephalexin | 19 | $59 | $3 |
| Metformin Hcl Er | 12 | $56 | $5 |
2022: 17 drugs
| Atorvastatin | 86 | $874 | $10 |
| Losartan | 58 | $666 | $11 |
| Midodrine | 12 | $638 | $53 |
| Rosuvastatin | 12 | $581 | $48 |
| Levothyroxine | 29 | $478 | $16 |
| Gabapentin | 14 | $360 | $26 |
| Montelukast | 20 | $260 | $13 |
| Zolpidem | 16 | $227 | $14 |
| Amlodipine Besylate | 33 | $202 | $6 |
| Metformin | 24 | $200 | $8 |
| Fluoxetine | 20 | $197 | $10 |
| Atenolol | 21 | $169 | $8 |
| Sertraline | 13 | $126 | $10 |
| Simvastatin | 11 | $119 | $11 |
| Lisinopril | 16 | $88 | $5 |
| Folic Acid | 11 | $61 | $6 |
| Alendronate | 21 | $48 | $2 |
2021: 11 drugs
| Rosuvastatin | 12 | $577 | $48 |
| Atorvastatin | 45 | $553 | $12 |
| Losartan | 30 | $380 | $13 |
| Gabapentin | 17 | $359 | $21 |
| Omeprazole | 11 | $264 | $24 |
| Levothyroxine | 12 | $223 | $19 |
| Simvastatin | 12 | $201 | $17 |
| Lisinopril | 15 | $172 | $11 |
| Amlodipine Besylate | 18 | $159 | $9 |
| Metformin | 15 | $149 | $10 |
| Atenolol | 11 | $99 | $9 |
2020: 9 drugs
| Atorvastatin | 38 | $680 | $18 |
| Metformin | 32 | $294 | $9 |
| Lisinopril | 29 | $281 | $10 |
| Gabapentin | 21 | $245 | $12 |
| Losartan | 19 | $238 | $13 |
| Amlodipine Besylate | 22 | $121 | $5 |
| Hydrochlorothiazide | 18 | $117 | $7 |
| Glipizide | 13 | $102 | $8 |
| Simvastatin | 14 | $102 | $7 |
2019: 26 drugs
| Symbicort | 28 | $16,812 | $600 |
| Basaglar Kwikpen U-100 | 16 | $4,049 | $253 |
| Ventolin Hfa | 24 | $1,962 | $82 |
| Atorvastatin | 124 | $1,850 | $15 |
| Gabapentin | 54 | $1,355 | $25 |
| Metoprolol | 20 | $712 | $36 |
| Lisinopril | 59 | $456 | $8 |
| Baclofen | 18 | $454 | $25 |
| Allopurinol | 18 | $400 | $22 |
| Metformin | 42 | $353 | $8 |
| Amlodipine Besylate | 45 | $317 | $7 |
| Losartan | 33 | $304 | $9 |
| Omeprazole | 12 | $253 | $21 |
| Fluticasone Propionate | 19 | $235 | $12 |
| Pantoprazole | 27 | $218 | $8 |
| Levothyroxine | 12 | $195 | $16 |
| Clopidogrel | 15 | $181 | $12 |
| Carvedilol | 18 | $180 | $10 |
| Metoprolol | 19 | $168 | $9 |
| Sertraline | 21 | $160 | $8 |
| Furosemide | 23 | $151 | $7 |
| Hydrochlorothiazide | 31 | $135 | $4 |
| Simvastatin | 15 | $133 | $9 |
| Escitalopram | 11 | $124 | $11 |
| Glipizide | 15 | $94 | $6 |
| Tramadol | 14 | $91 | $6 |
2018: 13 drugs
| Ventolin Hfa | 17 | $1,276 | $75 |
| Atorvastatin | 69 | $883 | $13 |
| Metoprolol | 12 | $399 | $33 |
| Gabapentin | 23 | $346 | $15 |
| Metformin | 35 | $238 | $7 |
| Lisinopril | 38 | $215 | $6 |
| Amlodipine Besylate | 22 | $147 | $7 |
| Hydrochlorothiazide | 21 | $87 | $4 |
| Metoprolol | 11 | $86 | $8 |
| Carvedilol | 11 | $82 | $7 |
| Glipizide | 16 | $81 | $5 |
| Cyclobenzaprine | 11 | $75 | $7 |
| Azithromycin | 11 | $49 | $4 |
Money from drug and device companies
$25 in 2019
A payment is not proof that care is biased.
| McKesson | None | $25 | 1 payment
|
See the published payment
| McKesson | Gift · 2019-02-11 | None | $25 |
Professional record
- NPI
- 1447540398
- Licence
- CA A151365, PA MD449205, PA MT196576California A151365: Current · expires 2026-11-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1300 Crane St, Menlo Park, CA, 94025
- NPI first listed
- 2011-04-12
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1316 W Ontario St, Philadelphia, PA, 19140